| scholarly article | Q13442814 |
| P2093 | author name string | Y S Kim | |
| R Risser | |||
| P2860 | cites work | A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator | Q24338540 |
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
| Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein | Q28247468 | ||
| Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 | Q28288094 | ||
| Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
| The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes | Q28291126 | ||
| Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression | Q28645850 | ||
| Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 | Q28646771 | ||
| Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product | Q29615049 | ||
| Ribonucleic acid isolated by cesium chloride centrifugation | Q29616561 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| Cellular uptake of the tat protein from human immunodeficiency virus | Q29620627 | ||
| HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
| HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
| An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat | Q33558271 | ||
| Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells | Q33567142 | ||
| Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus | Q33575002 | ||
| Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer | Q33581303 | ||
| High levels of heterodisperse RNAs accumulate in T cells infected with human immunodeficiency virus and in normal thymocytes | Q33582974 | ||
| Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein | Q33666097 | ||
| Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis | Q33834125 | ||
| Selective translation of heat shock mRNA in Drosophila melanogaster depends on sequence information in the leader | Q33931644 | ||
| Trans-activation by HIV-1 Tat via a heterologous RNA binding protein | Q34156002 | ||
| Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. | Q34161762 | ||
| The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
| HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. | Q34186306 | ||
| Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region | Q34284937 | ||
| Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
| Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. | Q34373627 | ||
| The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
| Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 | ||
| Expression of human class II major histocompatibility complex antigens using retrovirus vectors | Q34611661 | ||
| Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection | Q36262361 | ||
| The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection | Q36320006 | ||
| Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction | Q36357737 | ||
| High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice | Q36383218 | ||
| Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. | Q36802812 | ||
| The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. | Q36827125 | ||
| Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs | Q36903040 | ||
| Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components | Q36903371 | ||
| The role of envelope glycoprotein processing in murine leukemia virus infection | Q36918689 | ||
| Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus | Q37412665 | ||
| A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus | Q37538653 | ||
| Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products | Q37571081 | ||
| Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
| Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus | Q38348287 | ||
| Regulatory pathways governing HIV-1 replication | Q38360638 | ||
| A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
| TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes | Q41238682 | ||
| TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter | Q41724573 | ||
| Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. | Q41753194 | ||
| Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 | ||
| Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity | Q43894349 | ||
| Transcriptional but not translational regulation of HIV-1 by the tat gene product. | Q44298589 | ||
| HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
| Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition | Q44540333 | ||
| The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
| Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity | Q45227677 | ||
| A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction | Q45256281 | ||
| Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
| Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism | Q45830933 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro | Q45841300 | ||
| Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
| Structural arrangements of transcription control domains within the 5'-untranslated leader regions of the HIV-1 and HIV-2 promoters | Q46329660 | ||
| Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
| HIV-1 TAT "activates" presynthesized RNA in the nucleus | Q48291503 | ||
| New human and simian HIV-related retroviruses possess functional transactivator (tat) gene | Q48340140 | ||
| Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 | ||
| The preferential translation of Drosophila hsp70 mRNA requires sequences in the untranslated leader. | Q52467701 | ||
| Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. | Q55244517 | ||
| Translational control of SV40 T antigen expressed from the adenovirus late promoter | Q64380954 | ||
| Regulation of HIV-1 gene expression | Q68512606 | ||
| A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation | Q68583028 | ||
| Different requirements for formation of Jun: Jun and Jun: Fos complexes | Q69274554 | ||
| Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells | Q69343052 | ||
| The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV | Q69827093 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 239-248 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein | |
| P478 | volume | 67 |
| Q35870516 | Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. |
| Q40676905 | Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein. |
| Q24649124 | Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells |
| Q33851781 | Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions |
| Q41510614 | The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes |
| Q39683211 | The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. |
| Q24680024 | The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein |
| Q36649447 | The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. |
Search more.